tioning in leukemia survivors. 2 Several studies have also reported that children younger than 4 years may be particularly vulnerable to the neurotoxic effects of cranial radiChildren receiving a bone marrow transplant (BMT) are at risk for neuropsychological late effects because ation and/or chemotherapy. 3, 4 Finally, the fact that children receiving BMT are often placed in isolation for extended of potentially neurotoxic chemotherapy and total body irradiation. The goal of this study was to prospectively periods because of their immunosuppressed status places them at further risk for cognitive and psychosocial developand longitudinally assess the intellectual and adaptive functioning of children receiving a BMT. This study mental delays. The possible long-term developmental sequelae of BMT examined 67 children whose development was evaluated at baseline prior to BMT and at 1 year follow-up. Mean have not been extensively studied. Kaleita et al 5 and Halberg et al 6 followed small cohorts of children for 1 to 5 age at BMT was 45 months. Repeated-measures ANOVA indicated a significant decline in IQ between years and reported normal intellectual development. A recent paper by Phipps et al 7 described psychological measbaseline and the 1 year follow-up evaluation. Multivariate and exploratory univariate analyses examined the ures obtained 6-12 months post-BMT in a cohort of 25 children, and reported that cognitive and neuropsychologic potential influence of diagnosis, treatment regimen, cranial radiation dose, age at time of transplant, and function remained stable during the study period. Other studies that evaluated children at baseline and 1 year postsex of child but none of these independent variables predicted outcome. Twenty-six children (mean age at BMT BMT reported that the levels of cranial radiation used as part of the conditioning regimen were not associated with of 28.4 months) were also given developmental evaluations 3 years post-BMT. Although IQ at the 1 year significant developmental delays. 8, 9 In contrast, Smedler et al 10 reported delays in their three youngest leukemia follow-up was significantly lower than baseline, no further changes were evident at the 3 year follow-up patients who received total body irradiation (TBI) prior to BMT. Parth et al 11 reported impairments on two cognitive evaluation. Scores on the Vineland Adaptive Behavior Scales also dropped significantly between baseline and tasks in their group of BMT patients. Sanders 12 evaluated a large sample of children at baseline and 1 year post-BMT the 1 year follow-up, but did not change between the 1 year and 3 year evaluations.
Bone marrow transplantation (BMT) is used with increas-
The purpose of our study was to prospectively and longiing frequency for treating several pediatric disorders tudinally evaluate the global intellectual functioning and involving marrow stem cell defects, solid tumors, leukeadaptive behavior in a large cohort of children treated by mias and selected inborn errors of metabolism. Successful BMT. transplants have been done for infants within the first 3 months of life. Although BMT can be a life-saving procedure, pre-BMT conditioning regimens involving total Patients and methods body irradiation (TBI) and chemotherapy are neurotoxic. Radiation to the brain, for example, has long been associaSubjects ted with delays in intellectual development. Several investigators have reported deficits in IQ, memory, attention and
The patient population included all children receiving a visuospatial ability. 1 Chemotherapy without cranial radibone marrow transplant at the University of California, San ation has also been linked to declines in cognitive func- nificant and possibly progressive neurological dysfunction; these diagnoses included brain tumor (n = 7), mucopolysacleukemia/lymphoma received busulfan 16-18 mg/kg, CY 200-240 mg/kg, and ATG 80 mg/kg or CY 120 mg/kg and charidosis (eg Hurlers, Hunters; n = 10), and adrenoleukodystrophy (n = 2). Of the remaining 175 children, 142 were 12 Gy TBI in six fractions. Patients with neuroblastoma all received a TBI regimen (10 Gy in three fractions) preceded administered baseline measures of cognitive ability and adaptive behavior approximately 1 to 6 weeks prior to their by either a combination of cisplatin, VM26, adriamycin, melphalan, or more recently carboplatin, etoposide, and transplant. Five additional patients were excluded from further study because their baseline IQs were below 75, melphalan. leaving a final cohort of 137 children.
Of these 137 children, 67 children were re-evaluated Procedures approximately 1 year later. Seventy children did not receive a developmental evaluation at the 1 year follow-up interval:
Patients were scheduled for developmental evaluation just 43 because of death, three because of relapse, and 24 prior to BMT, at approximately 1 year post-BMT, and because of scheduling constraints, transportation difficultevery subsequent 2 years. The developmental evaluations ies, or transfer of care to other facilities. Two additional were typically included during one of the child's routine children received their follow-up evaluations less than 6 BMT clinic visits. Each developmental evaluation included months after BMT and were eliminated from the analyses.
global measures of intellectual functioning and adaptive The diagnoses for this final sample of 65 children included behavior. The global intellectual measure was the Bayley 14 severe combined immunodeficiency disease, neuroblasfor children under 2. years, the Stanford-Binet-IV 15 for toma, malignant hematological disorders (leukemia and children beween 2. and 6 years, and a version of the lymphoma), nonmalignant hematological disorders such as
Wechsler Intelligence Scale for Children (WISC) for chilthallasemia, immunodeficiency diseases other than SCID dren over the age of 6 years. Children evaluated with the (Wiskott-Aldrich, Chediak-Higashi), and germ cell tumor.
WISC prior to January 1994 were given the Wechsler IntelThe mean interval between baseline and follow-up was 14.5 ligence Scale for Children (revised (WISC-R 16 )); children months (range, 8.3-23.9 ). Diagnostic and demographic data evaluated at baseline with the WISC after January 1994 are summarized in Table 1. were given the Wechsler Intelligence Scale for Children Twenty-six of the final group of 65 children were also (3rd edition (WISC-III 17 )). To eliminate unnecessary error seen for developmental evaluations 3 years after their transvariance, however, all subsequent evaluations used the plant. Descriptive statistics on this sample are also summarsame version of the WISC originally administered to the ized in Table 1. child. Thus a child initially administered the WISC-R The conditioning protocols varied with the diagnosis and received the WISC-R on all later follow-up evaluations, over time. In general, SCID patients were treated with even if the evaluation occurred after January 1994. The either a non-TBI regimen (cyclophosphamide (CY) Vineland Adaptive Behavior Scale (VABS 18 ) was used to 200 mg/kg and/or ATG 80 mg/kg) or a TBI-containing quantify adaptive behavior. The Wide Range Achievement regimen consisting of CY 120 mg/kg, ATG 80 mg/kg, and Test (revised (WRAT-R 19 )) was administered to children 5 7 Gy unfractionated TBI with 50% shielding of the brain, years and older to assess academic skills, and the Beery eyes and lungs. 6 Patients with other immunodeficiency disTest of Visual-Motor Integration 20 was administered to eases, other marrow stem cell defects or children 4 years and older to assess visuospatial skills. were younger at time of transplant than the children not seen for follow-up (44.0 vs 99.1 months).
Baseline vs 1-year post-BMT
to reach statistical significance (P Ͼ 0.10). Additional analyses were carried out to investigate differences in the Because baseline data were obtained on all children in the VABS domain scores. The VABS provides separate scores study, changes in global cognitive functioning relative to for the domains of communication, daily living skills, socibaseline were evaluated using repeated-measures analysis alization and motor skills. Scores on the communication, of variance (ANOVA). Time (baseline vs 1 year post) was daily living skills and socialization domains are obtained the within-subject variable and IQ was the dependent varion children of all ages, whereas a score on the motor skills able. Sixty-three of the 65 children received an IQ test at domain is obtained only on children aged 5 years and both baseline and the 1 year follow-up. The ANOVA for IQ younger. A repeated-measures ANOVA was carried out yielded a significant main effect for time, F(1,62) = 14.13, using the 43 children who were young enough at both base-P Ͻ 0.001, with a significant drop in IQ between baseline line and 1 year follow-up to have received scores on all (IQ = 100.5; s.d. = 14.3) and 1 year follow-up (IQ = 94.5; four VABS domains. Time (baseline vs 1 year post) and s.d. = 16.7).
domain were within-subject variables. The ANOVA The preceding analyses were based on three different IQ resulted in significant main effects for domain, measures: the Bayley, Stanford-Binet-IV, and the WISC.
F(3,126) = 8.43, P Ͻ 0.001 and time, F(1,42) = 4.60, Combining scores from different measures is a necessary P Ͻ 0.05. Domain means and standard deviations are sumby-product of assessing children across a wide age range. marized in Table 3 . Univariate analyses indicated that the No two measures correlate perfectly, however, raising the motor domain was significantly lower than the communipossibility that using multiple tests might affect the results cation, daily living skills and socialization domains at both of the study. To address this issue, we examined all possevaluations. There were no other significant differences ible combinations of test measures between the baseline between domain scores. Scores at 1 year post-BMT were and 1 year follow-up. Children either had the Bayley at lower that at baseline. The time by domain interaction was both times (n = 22), the Bayley at baseline and the Stannot significant (P Ͼ 0.4). ford-Binet-IV at follow-up (n = 8), the Stanford-Binet-IV Differences between baseline and the 1 year follow-up at both times (n = 17), the Stanford-Binet-IV at baseline were also assessed by examining the variability of change and the WISC at follow-up (n = 5), or the WISC at both in the IQ and VABS composite scores. We operationally times (n = 11). Analysis of variance comparing the groups defined a significant change in score as an increase or on change in IQ between baseline and 1 year was nondecrease of more than two standard error of measurement significant (P Ͼ 0.5). A second analysis comparing children units. For both IQ and the VABS composite score, this whose IQ measure changed and those whose IQ measure translated into a change of seven or more points. The did not change was also non-significant. change in IQ ranged from an increase of 25 to a decrease To facilitate comparison between the current study and of 42. The majority of children exhibited a drop in IQ score, other studies of children receiving BMT, mean scores for however. Twenty-eight of the children declined seven or children treated with the same measure at both baseline and more points while 27 had relatively stable scores and eight the 1 year follow-up are presented in Table 2 . Mean scores children increased seven or more points. A comparable patfor subscales of the Stanford-Binet and WISC are also tern was observed with the VABS composite score. The reported, although repeated measures ANOVA indicated change in score ranged from an increase of 23 to a decrease that the subscales did not differ in terms of change over of 20; 22 dropped seven or more points, 20 had relatively time.
stable scores, and 14 showed an increase of seven or Changes in adaptive behavior relative to baseline were more points. evaluated with a repeated-measures ANOVA, with time (baseline and 1 year post) as the within-subject variable and
Multivariate analysis VABS composite score as the dependent variable. Fifty-six children received a VABS composite score at both baseline
Stepwise multiple regressions were carried out to determine and the 1 year follow-up. The main effect for time failed if age at time of transplant, diagnosis, sex, cranial radiation dose or chemotherapy (busulfan) dose could predict IQ or Table 2 Mean scores for subgroups of children receiving the same IQ VABS composite score at the 1 year follow-up. Baseline measure at baseline and 1 year follow-up IQ and VABS scores were forced into the equations first Radiation dose to control for baseline functioning. IQ at baseline was a Subjects were divided into two subgroups on the basis of significant predictor of IQ at the 1 year follow-up their radiation dose. Becasue of our focus on neurotoxicity, (r 2 = 0.45, P Ͻ 0.0001). None of the other independent the variable of interest was cranial radiation dose. Several variables remained in the regression equation. The same SCID patients receiving TBI had 50% shielding of the pattern emerged for the VABS. The baseline score was a brain, so their cranial radiation dose was half of the TBI significant predictor (r 2 = 0.24, P Ͻ 0.001), but no other dose. For the other diagnostic groups, the cranial radiation variables remained in the regression equation.
dose was the same as their TBI dose. Thirty-four children Although the multiple regressions did not suggest that received no cranial radiation, while 25 children received any of the predictor variables was strongly associated with doses greater or equal to 1000 cGy (mean dose = 1158 cGy; developmental outcome, additional exploratory analyses range = 1000 to 1200 cGy). Five cases receiving 350 cGy were carried out using univariate procedures. The effect of and one case receiving 480 cGy to the cranium were not diagnosis, treatment regimen, cranial radiation dose, and included in the analyses to provide a larger gap between age at time of BMT are reviewed in the following sections.
the irradiated and non-irradiated groups. Repeated-measures ANOVAs were carried out with the VABS composite Diagnosis and IQ scores between baseline and 1 year post-BMT. Main and interaction effects involving cranial radiation dose were The sample size for individual diagnostic groups was too non-significant for both developmental measures (see small to analyze statistically. The mean IQ and VABS com- Table 4 ). posite scores at baseline and 1 year post-BMT for each diagnostic group are summarized in Table 4 . A visual inspection of the data suggested that the five children with
Age at time of BMT the non-SCID disorders were most vulnerable to significant Several studies have suggested that younger children are at declines in functioning. A review of individual cases indigreater risk for cognitive and academic late effects after cated that four of the five cases (three with Wiskott-Aldrich exposure to potentially neurotoxic treatments. To further and one with Chediak-Higashi) had drops of 20 points or explore this question in our BMT sample, children were more in IQ, while one patient with Wiskott-Aldrich had grouped according to when they received their transplant. stable scores.
Twenty-nine children received their BMT prior to 2 years (mean age = 9.5 months) and 36 were transplanted after 2 Treatment years of age (mean age = 73.5 months). The younger group TBI and busulfan were considered the most potentially neureceived significantly less radiation to the brain (265.5 cGy rotoxic components of the pre-BMT regimens. Subjects vs 652.2 cGy). Repeated-measures ANOVAs yielded no were divided into four treatment groups; those receiving significant main or interaction effects of age at time of neither busulfan nor TBI (n = 12), those receiving busulfan transplant on IQ or VABS composite score (see Table 4 ). but no TBI (n = 22), those receiving TBI without busulfan (n = 26; mean cranial radiation dose = 1028.8 cGy), and Sex those receiving both TBI and busulfan (n = 5; mean cranial radiation dose = 886.0 cGy). Repeated-measures ANOVAs
The performance of the 28 boys and 35 girls assessed at the 1 year follow-up were compared to assess for possible were carried out with the VABS composite and IQ scores between baseline and 1 year post-BMT. Main and interacsex differences in the appearance of developmental late effects. Repeated-measures ANOVAs yielded no significant tion effects involving treatment group were non-significant for both developmental measures (see Table 4 ). differences for IQ or VABS composite score (see Table 5 ). 
3-year follow-up
As described in the Patients and methods section, 26 children were also seen for developmental evaluations 3 years after their transplant. The IQ data were analyzed with a repeated-measures ANOVA, with time (baseline vs 1 year post vs 3 years post) as a within-subject variable. The main effect for time was significant, F(2,50) = 4.68, P Ͻ 0.05. Post-hoc analyses indicated a drop in IQ between baseline and the 1-year follow-up; no further changes were noted in the 3-year follow-up. The repeated-measures ANOVA for the VABS composite score also yielded a significant main effect for time, F(2,38) = 3.69, P Ͻ 0.05. Again, scores dropped significantly between baseline and the 1 year follow-up, with relative stability noted at the 3 year evaluation. The IQ and VABS data are presented graphically in Figure 1 . Analyses were carried out on measures of visuospatial ability and academic proficiency at the 3 year follow-up evaluation. These data were not collected on most children at the baseline and 1 year follow-up assessments because the children were below the lower age limits for the tests. On the Beery, a measure of design copying, our BMT cohort (n = 12) scored in the average range (mean = 98.00; s.d. = 13.1). All mean scores on the WRAT-R, however, (s.d. = 13.2). A comparison between sample scores and population parameters (mean of 100; standard deviation of 15) using the Z-statistic indicated that all three WRAT-R yielded mixed results. No significant change in VABS composite score was found when the entire cohort was examsubtest scores were significantly below the population mean of 100 (P Ͻ 0.05).
ined. When analyses were restricted to the 43 children young enough to have received all four domain scores at both evaluations, results indicated a significant drop in VABS composite score between baseline and the 1 year Discussion follow-up. Examination of the individual domains of communciation, daily living skills, socialization and motor The global intellectual functioning and adaptive behavior of children undergoing BMT were evaluated at baseline skills assessed by the VABS indicated that the motor domain was significantly lower than the other three prior to BMT and 1 year after BMT. The IQ scores showed a significant drop between baseline and 1 year follow-up.
domains, although there were no significant differences between the domains in terms of their rate of decline Twenty-eight of the 65 children demonstrated a drop in IQ of seven points or more between baseline and their 1 year over time.
Cranial radiation, chemotherapy, age at time of treatfollow-up evaluation. Assessment of adaptive behavior ment, and sex have all been identified as risk factors for difficulties. Less than half of our sample was old enough neuropsychological sequelae following treatment for leuketo have been given the WRAT-R even at the 3 year followmia. 1, 4, 21 None of these risk factors, however, demonstrated up, however, and WRAT-R scores could be obtained on any clear relationship to IQ or adaptive behavior in this only a small number of children at baseline and at the 1 group of BMT patients. Multiple regressions predicting 1 year follow-up. Therefore, it is still premature to draw conyear follow-up scores yielded no significant relationships clusions about BMT's long-term effects on academic perbetween outcome and the predictor variables. More formance. exploratory univariate analyses assessing the relationships Our finding of significant declines in cognitive ability between outcome measures and diagnosis, radiation dose, following BMT is in direct contrast with several previous conditioning regimen, age at time of BMT, and sex also reports of BMT survivors, including our own initial studfailed to reach statistical significance.
ies. 5, 6, 7, 9 Phipps et al, 7 for example, found stable IQ and A smaller cohort of patients was also evaluated at 3 years WRAT-R scores during the first year post-BMT in a cohort post-BMT. On both the IQ and VABS composite, there was of 25 survivors. The difference between Phipps et al and a significant drop in scores between baseline and 1 year our present findings cannot be attributed to the different post-BMT, and relative stability of scores between the 1 length of follow-up, since we observed a drop in scores year and 3 year follow-up. after 1 year. One possible difference between the two studWhy children undergoing BMT show declines in IQ and ies is the age of the children evaluated; only four of the 25 VABS composite scores is not clear. These decreases occur children studies by Phipps et al were below 6 years of age, even when the children are not exposed to known neurowhile in the present study, the majority of children were toxic agents (ie busulfan and radiation) and, in fact, no sigbelow age 6 at time of transplant. This would imply that nificant differences in developmental outcome between the younger children are at greater risk for late effects folchildren receiving busulfan or TBI and children receiving lowing BMT. Our VABS data are consistent with this neither treatment were detected in this study. Two alternahypothesis. First, when children young enough to have tive explanations will need to be the subject of further received a VABS motor domain score were analyzed separresearch. First, psychosocial variables, including the length ately, there was a significant drop in VABS scores between of hospitalization, the length of isolation, and/or changes baseline and the 1 year follow-up. Second, our sample of in psychosocial variables (eg increased dependency, children followed for 3 years was younger at baseline than changes in parenting style) may have a negative impact on our larger cohort; when these data were analyzed separcognitive and behavioral development. This would be conately, the drop in VABS scores was again found to be statsistent with Phipps et al's 7 suggestion that the decreased istically significant. Thus, while our univariate analyses did opportunity for social interaction following BMT may be not suggest that children treated prior to 2 years of age had associated with a decline on measures of social comsignificantly different outcomes than children treated after petence. age 2, there remains the possibility that age at time of BMT Second, it remains possible that the variables currently influences long-term outcome. This possibility would also under study do play a significant role in long-term outcome, be consistent with findings reported by Smedler and but our small sample size limits our sensitivity to detect Bolme, 22 who reported that BMT recipients under the age these effects. As more children are seen for long-term folof 3 years and treated with TBI had moderate developmenlow-up and a broader range of neuropsychological meastal delay. ures are available for statistical analysis, the impact of preOne of the strengths of the present study was that it viously identified risk factors can be more clearly evaluated children from a broad age range. This required understood.
use of three different IQ measures, however. We do not Although the mean drop in IQ was relatively small (six believe that this had any significant impact on our findings. points, or approximately 1/3 of a standard deviation), the First, the IQ measures correlate fairly well (eg r 2 = 0.83 observed changes in intellectual and adaptive functioning for the WISC-R and Stanford-Binet
15
). Second, statistical are likely to be clinically meaningful for many children.
analyses indicated that there were no significant differences Over 40% of the children in the study experienced an IQ between the different IQ measures, or between children decline of more than two standard error of measurement who were administered the same IQ test at baseline and 1 units, and 39% dropped more than two standard error of year follow-up and children who were administered differmeasurement units on the VABS. A clearer picture of the ent tests at baseline and 1 year follow-up. Finally, a similar impact BMT may have on long-term development will pattern of decline over time was observed for the VABS, require longer follow-up, however. School performance is a measure that remained constant across all age groups. one of the best barometers of how clinically meaningful a Although the reasons underlying the mild decline in cogchange in IQ score is. Most of the children in the present nitive functioning and adaptive behavior in children receivstudy were evaluated as pre-schoolers, however, so acaing BMT are not yet clear, the results of this study indicate demic functioning as baseline was not measurable and only that BMT survivors are at risk for late effects. Their longa handful of children were in school at the 1 year followterm neuropsychological functioning, school performance, up. The 3 year follow-up data point to levels of academic and psychological well-being warrant close monitoring. ability that are significantly below the mean, however. This
Clinicians should be aware of these potential risks and be suggests that although the mean IQ scores at the 3 year prepared to implement appropriate school-based and psyfollow-up are still technically within the average range, children who have undergone BMT are at risk for school chosocial interventions when necessary. study of cognitive function following low-dose cranial radi-
